“
TL;DR
This PRISMA systematic review synthesized 168 studies on vernal keratoconjunctivitis (VKC) diagnosis and treatment published between January 2016 and June 2023. The review found that VKC diagnosis remains clinical with no validated pathognomonic biomarkers, and therapy ranges from antihistamines to topical immunomodulators and, rarely, surgery.